BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/20/2026 11:38:29 AM | Browse: 7 | Download: 0
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Anti-obesity medications impacting the eye: An emerging concern - a narrative review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Srishti Khullar, Arvind Kumar Morya, Sarita Aggarwal, Arshi Singh, Priya Sisodiya and Rannusha Morya |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arvind Kumar Morya, Additional Professor, Consultant, Principal Investigator, Researcher, Senior Researcher, Department of Ophthalmology, All India Institute of Medical Sciences, Bibi Nagar, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com |
| Key Words |
Anti-obesity drugs; Ocular side effects; Optic neuropathy; Diabetic retinopathy; Glaucoma |
| Core Tip |
Anti-obesity medicines are being used more than ever, especially glucagon-like peptide-1 receptor agonists and newer incretin-based therapies. Along with clear metabolic benefits, emerging reports suggest potential eye-related complications such as non-arteritic anterior ischemic optic neuropathy, early worsening of diabetic retinopathy, acute angle closure from uveal effusion, and vitamin A-related visual dysfunction. These risks appear biologically plausible through vascular, metabolic, and neuro-ophthalmic pathways, particularly during rapid weight loss or quick glycaemic change. Clinicians should stratify risk, counsel patients on warning symptoms, and ensure timely ophthalmic evaluation. |
| Citation |
Khullar S, Morya AK, Aggarwal S, Singh A, Sisodiya P, Morya R. Anti-obesity medications impacting the eye: An emerging concern - a narrative review. World J Methodol 2026; In press |
 |
Received |
|
2026-01-06 06:26 |
 |
Peer-Review Started |
|
2026-01-06 06:26 |
 |
First Decision by Editorial Office Director |
|
2026-01-09 09:01 |
 |
Return for Revision |
|
2026-01-09 09:01 |
 |
Revised |
|
2026-01-17 10:49 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-20 02:43 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-20 11:38 |
 |
Articles in Press |
|
2026-03-20 11:38 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345